In vivo regulation of chemokine activity by post-translational modification.
about
Resolution of Inflammation: What Controls Its Onset?Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironmentCitrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studiesGene expression in thiazide diuretic or statin users in relation to incident type 2 diabetes.CCL2 nitration is a negative regulator of chemokine-mediated inflammation.Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.Mechanisms of Regulation of the Chemokine-Receptor Network.Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.
P2860
Q26747410-02D0A447-0F3A-49A9-B22D-04F94078531CQ28072580-B4C7A7C4-1011-43C2-8350-4E465A9FD8D3Q28396481-D9B7375A-8242-41A5-A220-4F099234532CQ33602959-16069D25-115C-4713-AC0A-955F705628E3Q35528569-23619A39-076B-4455-A941-15173F279A53Q36065054-7BFC8F34-B951-4D56-BB9A-7F0696723217Q36955998-648E1E77-BD5B-460F-AE29-6ACEC509FAB9Q37610840-ECF72AFF-8704-4ADA-A3AE-162B4F9C1847Q37698743-61E8514A-0C8A-49A9-847A-79E95FF61320Q38678404-18B5BB0E-4703-42B2-A636-1690D4A43F30Q38681182-68225BD5-792F-449C-9CC2-2D6D4968E26FQ38863969-BB7948FA-34FD-4FEF-8F5E-27913804ADA1Q39126530-61289FD2-1BD1-4380-BD4C-080BF49C02C7Q42366882-2D4A9479-3E2F-4F20-A68E-1BC84CC2582CQ49524220-D9449B16-F26C-404E-A54D-C86EBAA1D8E2
P2860
In vivo regulation of chemokine activity by post-translational modification.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
In vivo regulation of chemokine activity by post-translational modification.
@en
type
label
In vivo regulation of chemokine activity by post-translational modification.
@en
prefLabel
In vivo regulation of chemokine activity by post-translational modification.
@en
P2860
P356
P1476
In vivo regulation of chemokine activity by post-translational modification
@en
P2093
Anneleen Mortier
Eva A V Moelants
P2860
P304
P356
10.1038/ICB.2013.16
P577
2013-04-30T00:00:00Z